Analysis of the influencing factors and patterns of comorbidity among the Zhuang population in Guangxi
-
摘要 目的:了解广西地区35~74岁壮族人群慢性病共病的患病情况及影响因素,为有针对性地进行慢性病管理与防控提供依据。方法:本研究数据源于“广西少数民族自然人群慢性病前瞻性队列研究”项目。该项目于2017—2019年对广西壮族自治区内35~74岁壮族人群采用方便抽样的方法进行调查。调查内容为包括了社会人口学特征、生活方式等信息在内的问卷调查、体格检查和血生化检测。采用多因素非条件logistic回归分析法分析慢性病共病的影响因素,用优势分析法计算影响因素对慢性病共病患病的贡献度,关联规则分析通过Apriori算法来完成,用于分析共病模式,并绘制共病网络图。结果:12 411例35~74岁壮族人群中共有慢性病患者7 806例,共病患者3 178例,慢性病共病率为25.61%。多因素非条件logistic回归分析结果显示,男性(OR=2.24,95%CI=2.02~2.49)、45~59岁(OR=1.91,95%CI=1.68~2.17)、≥60岁(OR=3.11,95%CI=2.72~3.56)、饮酒(OR=1.37,95%CI=1.23~1.53)、饮茶(OR=1.21,95%CI=1.08~1.36)及超重或肥胖(OR=3.00,95%CI=2.75~3.28)与慢性病共病高风险相关,而体力劳动工作者较非体力劳动者慢性病共病风险更低(OR=0.85,95%CI=0.77~0.94)。优势分析结果显示,对共病患病影响排前3位的因素分别为超重或肥胖(46.17%)、≥60岁(18.21%)、男性(21.74%)。在共病网络中,高血压患病率最高,处于中心的最大节点,关联规则分析筛选出9种强关联的共病模式,其中置信度和提升度最高的二元和三元模式均包含糖尿病。结论:广西地区壮族人群的慢性病共病影响因素主要涉及个体特征及生活行为因素,相关医疗卫生机构应根据不同群体特征加强慢性病共病高危人群的不良生活行为因素干预,并对慢性病共病防治进行规范化管理,提高人群健康水平。Abstract Objective: To understand the prevalence and influencing factors of comorbidity among Zhuang population aged 35-74 in Guangxi and provide a basis for targeted management, prevention, and control of chronic diseases. Methods: Data of the present study were sourced from "Prospective Cohort Study of Chronic Diseases in Guangxi Ethnic Minority Natural Population" project, which conducted a survey on Zhuang population aged 35-74 in Guangxi Zhuang Autonomous Region from 2017 to 2019 by a convenient sampling method. The survey included questionnaire investigation(e.g., demographic characteristics and lifestyle), physical examination, and blood biochemical testing. Multivariable unconditional logistic regression analysis was used to analyze the influencing factors of comorbidity, and dominance analysis was used to estimate the contribution of influencing factors to the prevalence of comorbidity. Association rule analysis was performed by Apriori algorithm to analyze comorbidity patterns and generate the comorbidity network. Results: There were 7, 806 patients with chronic diseases and 3, 178 patients with comorbidity among 12, 411 Zhuang population aged 35-74. The rate of comorbidity was 25.61%. Multivariable unconditional logistic regression analysis showed that men(OR=2.24, 95% CI=2.02-2.49), 45-59 years old(OR=1.91, 95% CI=1.68-2.17), ≥ 60 years old(OR=3.11, 95% CI=2.72-3.56), drinking alcohol(OR=1.37, 95% CI=1.23-1.53), drinking tea(OR=1.21, 95% CI=1.08-1.36), and overweight or obesity(OR=3.00, 95% CI=2.75-3.28) were associated with higher risk of comorbidity, while manual labor workers had a lower risk of comorbidity than non-manual workers(OR=0.85, 95% CI=0.77-0.94).The results of advantage analysis showed that the top three influencing factors of comorbidity were overweight or obesity(46.17%), ≥ 60 years old(18.21%) and male(21.74%). Hypertension had the highest prevalence and caught the largest node in the center of the comorbidity network. Association rule analysis screened nine strongly associated comorbidity patterns, among which the association rules of binary and ternary patterns with the highest confidence and lift were all including diabetes. Conclusion: The influencing factors of comorbidity among the Zhuang population in Guangxi mainly involve individual characteristics and lifestyle. Medical and health institutions should strengthen intervention on unhealthy lifestyle among high-risk population with comorbidity based on different characteristics, and standardize the prevention and treatment of comorbidity to improve the health level of the population.
-
Keywords
- comorbidity /
- Zhuang nationality /
- prevalence /
- influencing factor
-
-
[1] BENZIGER C P, ROTH G A, MORAN A E. The global burden of disease study and the preventable burden of NCD[J]. Global heart, 2016, 11(4):393-397.
[2] 中国居民营养与慢性病状况报告(2020年)[J].营养学报, 2020, 42(6):521.Report on the nutrition and chronic diseases status of Chinese residents 2020[J]. Acta nutrimenta sinica, 2020,42(6):521. [3] 王丽敏,陈志华,张梅,等.中国老年人群慢性病患病状况和疾病负担研究[J].中华流行病学杂志, 2019,40(3):277-283. WANG L M, CHEN Z H, ZHANG M, et al. Study of the prevalence and disease burden of chronic disease in the elderly in China[J]. Chinese journal of epidemiology, 2019,40(3):277-283.
[4] WHO. Global status report on noncommunicable diseases.2014[EB/OL].(2014-10-26)[2023-10-12].
[5] WANG S B, D'ARCY C, YU Y Q, et al. Prevalence and patterns of multimorbidity in northeastern China:a crosssectional study[J]. Public health, 2015, 129(11):1539-1546.
[6] GU J Y, CHAO J Q, CHEN W J, et al. Multimorbidity in the community-dwelling elderly in urban China[J]. Archives of gerontology and geriatrics, 2017, 68:62-67.
[7] 赵春艳,张国峰,张建明,等.北京市通州区25岁及以上人群糖尿病、高血压、高血脂共病现状及影响因素研究[J].医学动物防制, 2022, 38(8):719-722, 726. ZHAO C Y, ZHANG G F, ZHANG J M, et al. Study on the stituation and influencing factors of comorbidity of diabetes, hypertension, hyperlipidemia among residents aged 25 and above in Tongzhou District, Beijing[J]. Journal of medical pest control, 2022, 38(8):719-722, 726.
[8] 朱佩媛,雷方,乔彬,等. 2019年成都市金牛区老年人慢性病共病现况及其影响因素研究[J].预防医学情报杂志, 2023, 39(1):84-92. ZHU P Y, LEI F, QIAO B, et al. Comorbidity of chronic diseases and its influencing factors among the elderly in Jinniu District of Chengdu City in 2019[J]. Journal of preventive medicine information, 2023, 39(1):84-92.
[9] 陆伟江,杨进.广西慢性病综合防控示范区建设的实践与探索[J].中国慢性病预防与控制, 2021, 29(11):853-856. LU W J, YANG J. Practice and exploration on the construction of Guangxi demonstration zone for comprehensive prevention and control of chronic diseases[J]. Chinese journal of prevention and control of chronic diseases,2021, 29(11):853-856.
[10] 徐小伟,宁观华,柏立辉.高血压并高尿酸血症与2型糖尿病的相关性研究[J].中国城乡企业卫生, 2021, 36(7):151-152. XU X W, NING G H, BAI L H. Correlation between hypertension complicated with hyperuricemia and type 2 diabetes mellitus[J]. Chinese journal of urban and rural enterprise hygiene, 2021, 36(7):151-152.
[11] ZHONG L X, LIU S, QIU X Q, et al. High prevalence of hyperuricemia and associated factors among Zhuang adults:a cross-sectional study based on the ethnic minority population cohort in the southwestern China[J]. International journal of environmental research and public health, 2022, 19(23):16040.
[12] 中国高血压防治指南修订委员会,高血压联盟(中国,中华医学会心血管病学分会中国医师协会高血压专业委员会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56. WRITING GROUP OF 2018 CHINESE GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION, CHINESE HYPERTENSION LEAGUE, CHINESE SOCIETY OF CARDIOLOGY, CHINESE MEDICAL DOCTOR ASSOCIATION HYPERTENSION COMMITTEE.ET AL. 2018 Chinese guidelines for the management of hypertension[J]. Chinese journal of cardiovascular medicine, 2019, 24(1):24-56.
[13] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华内分泌代谢杂志, 2021, 37(4):311-398. CHINESE DIABETES SOCIETY. Guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)[J]. Chinese journal of endocrinology and metabolism, 2021, 37(4):311-398.
[14] 中华医学会内分泌学分会.中国高尿酸血症与痛风诊疗指南(2019)[J].中华内分泌代谢杂志, 2020, 36(1):1-13. ENDOCRINOLOGY BRANCH OF CHINESE MEDICAL ASSOCIATION. Guideline for the diagnosis and management of hyperuricemia and gout in China(2019)[J]. Chinese journal of endocrinology and metabolism,2020, 36(1):1-13.
[15] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华全科医师杂志, 2017, 16(1):15-35. JOINT COMMITTEE ON REVISION OF GUIDELINES FOR PREVENTION AND TREATMENT OF ADULT DYSLIPIDEMIA IN CHINA. Guidelines for prevention and treatment of dyslipidemia in adults in China(revised in 2016)[J]. Chinese journal of general practitioners,2017, 16(1):15-35.
[16] 中国肥胖问题工作组.中国成人超重和肥胖症预防与控制指南(节录)[J].营养学报, 2004,(1):1-4. CHINA OBESITY WORKING GROUP. Guidelines for the prevention and control of overweight and obesity in Chinese adults(Excerpt)[J]. Acta nutrimenta sinica,2004,(1):1-4.
[17] SHOU Y Y, SMITHSON M. Evaluating predictors of dispersion:a comparison of dominance analysis and Bayesian model averaging[J]. Psychometrika, 2015, 80(1):236-256.
[18] 马春芳,汤榕,杨晓花,等.基于健康社会决定因素的宁夏中老年人慢性病共病的影响因素研究[J].中国全科医学, 2024, 27(4):447-453. MA C F, TANG R, YANG X H, et al. Influencing factors of multimorbidity among middle-aged and elderly people in Ningxia based on social determinants of health[J]. Chinese general practice, 2024, 27(4):447-453.
[19] 任静林,李红娟. 1998-2018年我国居民慢性病患病率趋势与人群差异分析[J].卫生经济研究, 2022, 39(6):30-33. REN J L, LI H J. Trends and population differences of chronic disease prevalence from 1998 to 2018[J]. Health economics research, 2022, 39(6):30-33.
[20] 刘恒,马浇,黄浩,等.陕西成年人慢性病共病现状及其影响因素和共病模式研究[J].西安交通大学学报(医学版), 2023, 44(3):473-480. LIU H, MA J, HUANG H, et al. Prevalence, associated factors and patterns of multimorbidity of non-communicable diseases among adults in Shaanxi Province[J]. Journal of Xi'an Jiaotong university(medical sciences), 2023,44(3):473-480.
[21] 伍甜甜,朱娥,虞建英,等.湖南省成年居民慢性病患病现况及影响因素分析[J].预防医学, 2022, 34(11):1145-1149, 1155. WU T T, ZHU E, YU J Y, et al. Current prevalence and influencing factors of chronic diseases among adult residents in Hunan Province[J]. Preventive medicine, 2022,34(11):1145-1149, 1155.
[22] 颜玮.江西省常住居民常见慢性病及其危险因素流行现状和干预策略研究[R].江西省疾病预防控制中心,2021-08-13. YAN W. A study on the prevalence and intervention strategies of common chronic diseases and their risk factors among permanent residents in Jiangxi Province[R]. Jiangxi province, Jiangxi provincial center for disease control and prevention, 2021-08-13.
[23] 张可可,朱鸣雷,刘晓红,等.北京部分社区老年人共病及老年综合征调查分析[J].中国实用内科杂志, 2016,36(5):419-421. ZHANG K K, ZHU M L, LIU X H, et al. Investigation of multimorbidity and geriatric syndromes in the elder people in Beijing communities[J]. Chinese journal of practical internal medicine, 2016, 36(5):419-421.
[24] 赖锦佳,黄咏琪,黄奕敏,等.我国中老年人慢性病共病与健康相关行为的关联性分析[J].现代预防医学, 2023,50(15):2804-2810. LAI J J, HUANG Y Q, HUANG Y M, et al. Analysis of the relationship between chronic comorbidities and healthrelated behaviors among the middle-aged and elderly in China[J]. Modern preventive medicine, 2023, 50(15):2804-2810.
[25] 吴梦怡,胡劲松,黄霜,等.湖南省30岁及以上社区居民高血压、糖尿病、高血脂共病的影响因素分析[J].预防医学, 2021(2):157-161. WU M Y, HU J S, HUANG S, et al. Prevalence and comorbidity factors of hypertension, diabetes and hyperlipidemia among community residents aged 30 years or over in Hunan Province[J]. Preventive medicine, 2021(2):157-161.
[26] 耿叶,介万,张思佳,等.慢性病共病流行现状及防治的研究进展[J].中国慢性病预防与控制, 2023, 31(1):71-75. GENG Y, JIE W, ZHANG S J, et al. Research progress on epidemic status and prevention of chronic diseases comorbidity[J]. Chinese journal of prevention and control of chronic diseases, 2023, 31(1):71-75.
[27] KEETILE M, NAVANEETHAM K, LETAMO G. Prevalence and correlates of multimorbidity among adults in Botswana:a cross-sectional study[J]. PLoS One, 2020,15(9):e0239334.
[28] BURCH J B, AUGUSTINE A D, FRIEDEN L A, et al. Advances in geroscience:impact on healthspan and chronic disease[J]. The journals of gerontology:series A, 2014,69(Suppl_1):S1-S3.
[29] CORTEZ-PINTO H, GOUVEIA M, DOS SANTOS PINHEIRO L, et al. The burden of disease and the cost of illness attributable to alcohol drinking-results of a national study[J]. Alcoholism, clinical and experimental research,2010, 34(8):1442-1449.
[30] RUEGSEGGER G N, BOOTH F W. Health benefits of exercise[J]. Cold Spring Harbor perspectives in medicine,2018, 8(7):a029694.
[31] CAO Z, XU C J, ZHANG P J, et al. Associations of sedentary time and physical activity with adverse health conditions:outcome-wide analyses using isotemporal substitution model[J]. EClinicalMedicine, 2022, 48:101424.
[32] CARTER S, HARTMAN Y, HOLDER S, et al. Sedentary behavior and cardiovascular disease risk:mediating mechanisms[J]. Exercise and sport sciences reviews, 2017,45(2):80-86.
[33] BELLETTIERE J, LAMONTE M J, EVENSON K R, et al. Sedentary behavior and cardiovascular disease in older women:the objective physical activity and cardiovascular health(OPACH)study[J].Circulation, 2019, 139(8):1036-1046.
[34] 胡志昊,王娜,刘星,等.饮茶与常见慢性疾病及生化指标的相关性研究[J].中国慢性病预防与控制, 2021,29(11):847-850. HU Z H, WANG N, LIU X, et al. Study on the correlation between drinking tea and common chronic diseases and biochemical indexes[J]. Chinese journal of prevention and control of chronic diseases, 2021, 29(11):847-850.
[35] CHEN Y C, ZHANG Y, YANG H X, et al. Association of coffee and tea consumption with cardiovascular disease,chronic respiratory disease, and their comorbidity[J]. Molecular nutrition&food research, 2022, 66(24):e2200419.
[36] KIVIMÄKI M, STRANDBERG T, PENTTI J, et al. Bodymass index and risk of obesity-related complex multimorbidity:an observational multicohort study[J]. The lancet diabetes&endocrinology, 2022, 10(4):253-263.
[37] ZHANG J, XU L Z, LI J J, et al. Association between obesity-related anthropometric indices and multimorbidity among older adults in Shandong, China:a cross-sectional study[J]. BMJ open, 2020, 10(5):e036664.
[38] 赵叶茂.四川省老年人慢性病共病模式及其相关因素研究[D].成都:成都医学院, 2022. ZHAO Y M. Study on the comorbidity model of chronic diseases among the elderly in Sichuan Province and its related factors[D].Chengdu:Chengdu medical college, 2022.
[39] 刘丹妮,郑杨,刘晓侠,等.上海市社区老年居民主要慢性病共病流行情况[J].江苏预防医学, 2023, 34(1):24-27. LIU D N, ZHENG Y, LIU X X, et al. Prevalence of comorbidity in chronic diseases among the elderly community residents in Shanghai[J]. Jiangsu journal of preventive medicine, 2023, 34(1):24-27.
[40] JI L, HU D, PAN C, et al. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients[J]. The American journal of medicine.2013, 126(10):925.
[41] 徐小兵,李迪,孙扬,等.基于关联规则的中国老年人慢性病共病分析[J].中国慢性病预防与控制, 2021,29(11):808-812. XU X B, LI D, SUN Y, et al. Analysis of chronic diseases comorbidity among the elderly in China based on association rules[J]. Chinese journal of prevention and control of chronic diseases, 2021, 29(11):808-812.
-
期刊类型引用(5)
1. 赵延芳,王雪飙,邹媛,姚华. 我国老年人慢性病共病模式及健康管理策略建议. 中华健康管理学杂志. 2025(01): 8-13 . 百度学术
2. 郑浩渠,王莹莹,庄岚清,李璋恒,刘辰,郭丹. 老年住院患者心血管代谢性共病分布及影响因素研究. 中国病案. 2025(03): 44-47 . 百度学术
3. 李亚群,张敏. 某市辅警人员健康相关行为现状研究. 卫生职业教育. 2025(08): 111-115 . 百度学术
4. 赵璨,申颖,奚谦,彭厚瑄,覃金琼,王璇,郑艳萍,覃丽,左延莉. 广西壮族自治区乡镇卫生院多重慢病患者的住院费用及影响因素研究. 中国全科医学. 2025(16): 2039-2049 . 百度学术
5. 贾海霞,张瑞珍. 基于信息协作平台的干预模式在内分泌科室中的管理效果及对管理质量的影响研究. 中国卫生产业. 2024(19): 130-133 . 百度学术
其他类型引用(1)
计量
- 文章访问数: 134
- HTML全文浏览量: 2
- PDF下载量: 26
- 被引次数: 6